首页> 外文期刊>Obesity >Characteristics associated with fasting appetite hormones (obestatin, ghrelin, and leptin).
【24h】

Characteristics associated with fasting appetite hormones (obestatin, ghrelin, and leptin).

机译:与空腹食欲激素(obestatin,ghrelin和leptin)相关的特征。

获取原文
获取原文并翻译 | 示例
           

摘要

Obestatin, derived from the same gene as the hunger hormone ghrelin, may reduce food intake in animals. The role of obestatin in human physiology is unclear. We evaluated cross-sectional associations between participant characteristics and fasting levels of obestatin as well two other hormones associated with energy balance, ghrelin and leptin. Data are from the baseline visit of the Optimal Macronutrient Intake Trial to Prevent Heart Disease (OMNI-Heart) Trial that enrolled adults with elevated blood pressure (systolic 120-159 mm Hg or a diastolic of 80-99 mm Hg) but who were otherwise healthy. Partial Spearman's correlations and linear regression models estimated the association between age, gender, BMI, physical activity, and smoking with fasting hormones. Obestatin was directly associated with ghrelin (r = 0.45, P < 0.05). On average, overweight (BMI 25-30) and obese (BMI > 30) individuals had obestatin concentrations that were 12.6 (s.d. 8.8) and 25.4 (s.d. 8.4) pg/ml lower compared to normal weight (BMI < 25) individuals, respectively (P for trend = 0.002). Overweight (BMI 25-30) and obese (BMI > 30) individuals had ghrelin concentrations that were 161.7 (s.d. 69.6) and 284.7 (s.d. 66.5) pg/ml lower compared to normal weight (BMI < 25) individuals, respectively (P for trend <0.0001). A 5 unit increase in BMI was associated with 41.3% (s.d. 4.3%) (P < 0.0001) higher leptin. Obestatin and ghrelin are directly correlated and share the same patterns of association with participant characteristics. Modifiable risk factors for chronic diseases, such as BMI, are associated with fasting levels of leptin, obestatin, and ghrelin.
机译:肥胖抑制素的来源与饥饿激素ghrelin相同,可以减少动物的食物摄入。肥胖抑制素在人类生理学中的作用尚不清楚。我们评估了参与者特征与肥胖素禁食水平以及与能量平衡相关的其他两种激素(生长素释放肽和瘦素)之间的横断面关联。数据来自预防心脏病的最佳常量营养素摄入最佳试验(OMNI-Heart)试验的基线随访,该试验招募了血压升高(收缩压120-159 mm Hg或舒张压80-99 mm Hg)的成年人,健康。 Spearman的部分相关性和线性回归模型估计了年龄,性别,BMI,体力活动和吸烟与空腹激素之间的关联。肥胖抑制素与生长激素释放肽直接相关(r = 0.45,P <0.05)。平均而言,超重(BMI 25-30)和肥胖(BMI> 30)个体的肥胖抑制素浓度分别比正常体重(BMI <25)个体低12.6(sd 8.8)和25.4(sd 8.4)pg / ml。 (趋势的P = 0.002)。与正常体重(BMI <25)个体相比,超重(BMI 25-30)和肥胖(BMI> 30)个体的生长素释放肽浓度分别降低161.7(sd 69.6)和284.7(sd 66.5)pg / ml。趋势<0.0001)。体重指数增加5个单位与瘦素增加41.3%(标准误4.3%)(P <0.0001)有关。 Obestatin和Ghrelin是直接相关的,并具有与参与者特征相同的关联模式。慢性疾病(例如BMI)的可更改风险因素与瘦素,肥胖抑制素和生长素释放肽的禁食水平相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号